Parnassus Growth Equity Fund stated that Twist Bioscience is a biotechnology company with a proprietary silicon-based DNA synthesis platform that enables AI-powered drug discovery and next-generation sequencing, providing a lasting competitive advantage. As of September 15, Twist Bioscience's stock price was $138.10, having surged 443.64% over the past 52 weeks.